ipratropium/salbutamol is a formulation containing ipratropium bromide and salbutamol sulfate (albuterol combivent more drug side effects used in the management of chronic obstructive pulmonary disease (COPD) and asthma. It is marketed by combivent more drug side effects Ingelheim as metered dose inhaler (MDI) and nebuliser preparations under the trade name.

antagonistSalbutamol Short-acting ?2-adrenergic agonistIdentifiersCAS number ?ATC code ?PubChem ?Therapeutic considerationsPregnancy combivent more drug side effects ?Legal statusRoutes InhalationThe combination preparation ipratropium/salbutamol is a formulation containing ipratropium bromide and salbutamol sulfate (albuterol sulfate) used in the management of chronic obstructive pulmonary disease (COPD) and asthma. It is marketed by Boehringer Ingelheim as combivent more drug side effects dose inhaler (MDI) and nebuliser preparations under the trade name Combivent.[hide]v • combivent more drug side effects • eDrugs for obstructive airway diseases: asthma/COPD (R03)Adrenergics, inhalants Short acting combivent more drug side effects Salbutamol/Levosalbutamol • Fenoterol combivent more drug side effects TerbutalineLong acting ?2-agonists (LABA): Bambuterol • Clenbuterol • Formoterol • Salmeterolother: Epinephrine • Isoproterenol • OrciprenalineGlucocorticoids Beclometasone • combivent more drug side effects • Ciclesonide • Fluticasone • MometasoneAnticholinergics Ipratropium • TiotropiumMast cell stabilizers Cromoglicate cell.

Pharmacology stubs | Bronchodilators.